The drop occurred from mid Jan through March so I don't think approval was expected at that point.
It's either legal or more competition coupled with 3x dosing. My guess is a more crowded field which would take any of our early estimates and start dividing them between competition which would make the final numbers look ugly.
Market Data 
Markets 
AI
